Patents/Assignees

Neomatrix Therapeutics Inc.

1 patent in portfolio

US11548935utility2023
Peptides Derived from Fibronectin with Improved Bioactivity and Reduced Susceptibility to Neutrophil Elastase Degradation
0 cites